Follow The Filings

CDLX Cardlytics

Cardlytics earnings company data as of 11:02 AM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 5 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by CDLX's executives, directors and 10% owners in the last 12 months, from their Form 4s

All CDLX insider trades
  • $129K bought by 1 insider
  • $171K sold by 1 insider outside a trading plan
  • None no planned (10b5-1) sales
  1. Amit Gupta CEO
    Sale
    $47K 17,733 shares at $2.64 11% of stake
    Traded Oct 1–2 Filed Oct 2
    ↗
  2. Amit Gupta CEO
    Sale
    $54K 13,461 shares at $4.00 9.7% of stake
    Traded Aug 17–18 Filed Aug 18
    ↗
  3. Amit Gupta CEO
    Sale
    $71K 16,138 shares at $4.39 12% of stake
    Traded Jul 2–6 Filed Jul 6
    ↗
  4. David Thomas Evans CFO
    Buy
    $129K 200,000 shares at $0.6500 +170% to stake
    Traded May 15–18 Filed May 19
    ↗

Also filed in the last 12 months, not counted as buying or selling: 31 option exercises and 10 sales to cover taxes.

SEC filings

Recent issuer filings from EDGAR, 14 shown.

Filed Form Detail Links
8-K 1.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 3.01,3.03 Filing Doc
8-K 5.07 Filing Doc
8-K 5.02 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
8-K 2.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-K Filing Doc
8-K 1.01 Filing Doc

Source: SEC EDGAR submissions, updated 5 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.